Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
The WHO just released the latest statistics on what has turned into the largest ever outbreak of Ebola virus (EBOV) in Africa. The epidemic started in Guinea around December 2013. As of 7/27/2014, Guinea, Liberia, Nigeria, and Sierra Leone have reported a total of 1323 cases, with 729 fatalities [i]. Most Continue reading Ebola – Fact Sheet (Updated 10/3/2014)
There are currently a total of 6 beta-lactam + beta-lactamase inhibitor combinations in clinical trials. It will be a steep learning curve for the pharma reps (and physicians) to understand the resistance classifications, the confusing ESBL definitions, the CRE nomenclature, and how this all matters in clinical practice, on the Continue reading What is the “Niche” for Ceftolozane / Tazobactam?
The recent discussion whether fluoroquinolones (FQ) cause retinal detachment was short-lived and soon put to rest. The issue was raised by 2 observational studies but no signal was seen in a larger and better designed Danish study. So it seems the association is probably spurious [i].